Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
4(27%)
Results Posted
38%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
2
13%
Ph early_phase_1
1
7%
Ph not_applicable
11
73%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
2(14.3%)
N/ANon-phased studies
11(78.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
Recruiting4
Suspended2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
88.9%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (7.1%)
Phase 12 (14.3%)
N/A11 (78.6%)

Trials by Status

completed853%
recruiting427%
suspended213%
terminated17%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
DEVICE
Total Trials
15